EBioMedicine · 2019 · 49 citations · 71 references
MedicineNeurologyNeuroscienceCognitive NeurologyAntiretroviral TherapyAtp HydrolysisCognitive DisordersCognitive ImpairmentCognitive SymptomsMitochondrial DysfunctionAcquired Immunodeficiency SyndromeCognitive BiomarkersHiv-associated Cognitive Impairment
BACKGROUND: In developed countries, Human Immunodeficiency Virus type-1 (HIV-1) infection has become a chronic disease despite the positive effects of anti-retroviral therapies (ART), but still at least half of the HIV infected population shown signs of cognitive impairment. Therefore, biomarkers of HIV cognitive decline are urgently needed. METHODS: and ATP as well as cogntive status of the individuals analyzed. FINDINGS: and ATP were detected. Circulating levels of ATP were correlated with cognitive decline in the HIV-infected population supporting that ATP is a biomarker of cognitive disease in the HIV-infected population. INTERPRETATION: We propose that circulating levels of ATP could predict CNS compromise and lead to the breakthroughs necessary to detect and prevent brain compromise in the HIV-infected population.
71
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy
Robert K. Heaton, David B. Clifford, Donald Franklin et al. · Neurology · 2010 · 2.3K citations · Full text
Medicine, Neurology, Psychiatry +17
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Michael R. Elliott, Faraaz B. Chekeni, Paul C. Trampont et al. · Nature · 2009 · 1.6K citations · Full text